Trends in breast cancer incidence, survival, and mortality

H Pujol

Comment

H Pujol. Lancet. 2000.

. 2000 Aug 12;356(9229):591-2; author reply 593.

doi: 10.1016/S0140-6736(05)73968-4.

H Pujol

No abstract available

Comment on

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.
Veronesi U, Maisonneuve P, Costa A, Sacchini V, Maltoni C, Robertson C, Rotmensz N, Boyle P. Veronesi U, et al. Lancet. 1998 Jul 11;352(9122):93-7. doi: 10.1016/s0140-6736(98)85011-3. Lancet. 1998. PMID: 9672273 Clinical Trial.
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J. Powles T, et al. Lancet. 1998 Jul 11;352(9122):98-101. doi: 10.1016/S0140-6736(98)85012-5. Lancet. 1998. PMID: 9672274 Clinical Trial.
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.
Peto R, Boreham J, Clarke M, Davies C, Beral V. Peto R, et al. Lancet. 2000 May 20;355(9217):1822. doi: 10.1016/S0140-6736(00)02277-7. Lancet. 2000. PMID: 10832853 No abstract available.